Stocks · Health care · Pharmaceutical Preparations

Contineum Therapeutics, Inc.

CTNM Clue Score32
United States Fiscal year ends December CIK 0001855175 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.86M
$385.01K on a plan · $1.47M straight out of an exercise
Sold at will
$0.00
0 of 31 sales
Net
−$1.86M
$0.00 against sales at will